Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer

समान संसाधन

• PIK3CA gene mutations in the helical domain correlate with high tumor mutation burden and poor prognosis in metastatic breast carcinomas with late-line therapies
  द्वारा: Tang, Yu, और अन्य
  प्रकाशित: (2020)
• Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers
  द्वारा: Hu, Zhe-Yu, और अन्य
  प्रकाशित: (2020)
• Clinical and genetic risk factors for Fulvestrant treatment in post-menopause ER-positive advanced breast cancer patients
  द्वारा: Liu, Jingyu, और अन्य
  प्रकाशित: (2019)
• Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance
  द्वारा: Hu, Zhe-Yu, और अन्य
  प्रकाशित: (2018)
• Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
  द्वारा: Wilcken, Nicholas, और अन्य
  प्रकाशित: (2003)